The latest immunotherapy news and developments
A personalised cancer vaccine markedly improved outcomes for patients suffering from acute myeloid leukaemia (AML),…
QIMR Berghofer scientists have found that reversing the order of treatment for patients with certain…
Researchers at the University of Cincinnati (UC) have discovered that an ion channel, active within…
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialisation of individualised immunotherapies…
Using synthetic DNA sequences as the tiniest of barcodes, Technion researchers have developed a new…
Patients with malignant melanoma – whose disease has spread – are more likely to respond…
A research team including professor Peter Timmerman of the University of Amsterdam’s Van ‘t Hoff…
In people with chronic infections or cancer, disease-fighting T cells tend to behave like an…
According to results from a first-in-human phase I clinical trial published in Clinical Cancer Research, a…
Cancer evolution can lead to the emergence of drug resistance, so the ICR and The…